StonvexLoading…
StonvexStonvexStonvexCore line items from EPAM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.46B | $4.73B | $4.69B | $4.82B |
Operating Income | $520.00M | $544.58M | $501.24M | $572.97M |
Net Income | $377.68M | $454.53M | $417.08M | $419.42M |
EPS (Diluted) | $6.72 | $7.84 | $7.06 | $7.09 |
Total Assets | $4.90B | $4.75B | $4.35B | $4.01B |
Total Liabilities | $1.22B | $1.12B | $880.89M | $1.01B |
Cash & Equivalents | $1.30B | $1.29B | $2.04B | $1.68B |
Free Cash Flow OCF − CapEx | $612.69M | $527.02M | $534.22M | $382.48M |
Shares Outstanding | 54.27M | 56.87M | 57.79M | 57.66M |